Abstract

Diabetes is one of the most common diseases that are more prevalent in Pakistan. One of the major vascular complications of diabetes is peripheral arterial disease (PAD), which is associated with peripheral vascular damage and cardiovascular diseases. This complication enhances the risk of disability due to amputation of lower extremity in the patients suffering from diabetes. The early diabetic diagnosis and with therapy of the peripheral arterial disease, patients can minimize the risks of microvascular and macrovascular damage and resulting peripheral arterial disease. Thus, this step can help to reduce the cardiovascular complications and risks of amputation of extremity in such patients. The early diagnosis includes the assessment of blood sugar level. HBA1c is one of the standard markers to check the diabetes status in patients. The clinical presentations including polydipsia, polyuria and increased thirst also indicate towards diabetes susceptibility. The development of diabetes complications including neuropathy, myopathy, retinopathy, nephropathy and peripheral arterial disease point towards the sustained increased level of blood sugar (glucose) and condition is known as uncontrolled diabetes. The development of PAD can be prevented by early recognition of disease onset and by controlling the blood sugar level.

Keywords: Amputation; Diabetes Mellitus; Glucose; Hba1c; Lower Extremity; Peripheral Arterial Disease

Introduction

Diabetes

In the past five years, changes in lifestyle and globalization have led to significant changes in society, political systems, the environment, and human behavior. In underdeveloped and developing countries, the number of patients with diabetes and obesity has increased significantly [1-2]. Diabetes is now a major problem spread over the world and causing death in most countries [3]. In 2013, the International Diabetes Federation (IDF) estimated that there are approx. 382 M people worldwide suffer from diabetes, and this number is expected to increase to 592 million by 2035 [4]. It is the endocrine disorder in which the blood glucose/sugar level is very high as compared to the normal levels. The food is main source of glucose for the body. For the transportation of glucose into the cells and production of energy from it is done under the influence of a hormone, called insulin. The impaired insulin production and utilization of insulin by the body causes diabetes [5]. Diabetes is a chronic complex metabolic disorder, which requires continuous and regular medical care and checkup including multifactorial strategies to minimize the risks of complications’ development, presented clinically as the sustained and continuous hyperglycemic state in the body. Prolonged hyperglycemia can cause a large number of complications -renal, ocular, cardiovascular, and other recurrent infection. Studies have shown its high prevalence markedly in the developing countries or in the countries with lower to middle income status [5].

Diabetes and Insulin

The National Institutes of Health has been invested almost $ 200 million in diabetes research. Human fluids have recently appeared, and oral medications are only sulfonylurea. Insulin pump technologies and home plasma glucose monitoring are still in the “early stages.” Pancreas transplantation was almost unsuccessful, and the surgical mortality rate was 25%. Only 30% of patients have not used insulin for more than 1 year, and the islet transplantation is unsuccessful. The incidence of diabetes across the country is now alarmingly increasing. In 2003, 13.8 M people in the United States were diagnosed with diabetes, including 5 million undiagnosed diabetes and 41 million pre-diabetic patients. Since 1990, due to demographic changes, the prevalence of diabetes has increased almost every year, especially among ethnic minorities, the increase in the incidence of diabetes, the increase in awareness and discovery of diabetes, the change in diagnostic criteria, and the consequent increase and microvascular complications, The further increase in individuals along with obesity, leads to insulin resistance, which leads to diabetes. The cost of the disease is 92 billion U.S. dollars, and the research investment in 2002 was slightly less than 800 M U.S. dollars [6]. Blood glucose level is regulated by insulin. Insulin is an endocrine hormone which is produced and secreted by beta cells of pancreas. Insulin performs its action by binding to the insulin receptors on outer membranes of the cells for the glucose uptake. The activation of receptors, release of insulin and uptake of glucose by the cells is regulated by downstream cell signaling pathway. The impaired secretion or binding both leads to impaired glucose uptake by the cells and resulting hyperglycemia [7].

Types of Diabetes

There are 3 major types of diabetes, Type-1, Type-2 and gestational. First one is linked with the insulin sensitivity. Second one is linked with beta cells problems that are released by pancreases. And third one is related with hormonal changes that take place during pregnancy [8].
Type 1 Diabetes: Type-1 diabetes is insulin dependent diabetes or Juvenile diabetes is an autoimmune disease, presented in childhood, chronic in nature caused by insulin deficiency resulting hyperglycemia. This condition requires the administration of insulin in the body daily [8]. It is caused by autoimmune destruction of endocrine pancreas’ β cells. The process of this autoimmune destruction is influenced by genetic factors after being triggered by any environmental factor and progresses with passage of time from months to years. The increased knowledge regarding this type of diabetes regarding its onset, epidemiology, genetics and treatment due to increased research and investigations has increased the burden of disease and helped to improve the management criteria and protocol but still it is one of the common diseases globally [9]. The onset of type 1 DM is usually abrupt and is seen in people of age less than 30 years. It can be fatal unless diagnosed and managed as soon as possible. In 90℅ individuals it is autoimmune while in 10% of individuals it is idiopathic. If remains untreated, type 1 DM can become complicated and results ketoacidosis. It is observed that it is seen mostly in young children of age 10-14 years, but sometimes also seen in adults. Type 1 DM is considered to be a catabolic in nature which is characterized by absence or reduced insulin circulating in body. Levels of plasma glycogen is elevated, and the beta cells of pancreas fail to respond to the insulin secretion stimuli. Insulin injections are required to improve the metabolic disturbed state, reduce the plasma glycogen levels, avoid ketoacidosis and reduce glucose level of in blood [10].
The contributing and predisposing factors of type 1 diabetes are as follow [11].
Type 2 Diabetes: The type 2 diabetes in also known as insulin independent or diabetes mellitus that is one of the most prevalent disease today. The pathophysiology and causes of this disease are a bit complex and is associated with non-modifiable and modifiable risk factors. Modifiable risk factors include lifestyle, high blood pressure, smoking, poor diet, and obesity. Unchangeable risk factors include age, race, genetics, and ethnicity. By definition, the diabetes is a metabolic or endocrine disease characterized by increased glucose level either due to decreased action of insulin or decreased secretion of insulin. The uncontrolled diabetes can lead to damage to vital organs i.e., cardiovascular system, nerves, kidneys and eyes. In diabetes mellitus, increased HBA1c level also considered to be a cause of macrovascular and microvascular damages [12]. T2DM is more common as compared with T1DM. It usually remains asymptomatic and usually diagnosed by chance. This is chronic in nature and gradually develops. It is more common in elderly and middle-aged people. As compared to T1DM it is usually milder, compatible with life and ketoacidosis usually doesn’t develop. If proper management and treatment is given, the survival rate is high. The clinical presentation of T2DM can be seriously complicated in the presence of comorbid conditions [10] Figure 1.

Complications of Diabetes Mellitus

Diabetics are at higher risk for developing the following conditions that affect their ability to survive. Diabetes mellitus is characterized by multiple microvascular like retinopathy, nephropathy, neuropathy in addition to macrovascular such ischemic heart disease, cerebrovascular disease, and peripheral vascular disease [13]. This hormonal and metabolic disorder is one of the most common endocrine diseases affecting about 6% of the world’s population [14]. The type of diabetes associated with coronary artery disease and other forms of heart disease is T2DM. It is characterized by long pregnancy periods in which insulin resistance is predominant, and hormones produce insulin with B-cell compensation, which is sufficient to maintain normal blood sugar. The work of Raven and colleagues has shown that coronary artery disease is increasingly associated not only with diabetes, but also with insulin resistance [13]. Type-2 diabetes-related heart disease is a type of epicardial coronary artery disease, including sudden cardiac death and severe coronary syndrome, unstable angina, and severe myocardial infarction; Small vessel coronary artery disease; Mental illness; Peripheral vascular disease; Hypertension; and heart failure [15].

Gestational Diabetes: Suffering from this type of diabetes is at risk of development of complications during whole pregnancy and delivery. The child born to such mother also remains at risk of type 2 diabetes in future [8]. In gestational diabetes, the blood glucose levels are above the normal values but remains below the diagnostic value of diabetes [10].

Prevalence of Diabetes: In the meeting of NDSP (2016- 17), the diabetes prevalence recorded was 26.3%, out of which approximately 19% were chronic diabetic patients while approximately 7% were newly declared diabetic patients [16]. The increase in diabetes prevalence rate indicates the increase in the occurrence of risk factors. The prevalence rate of diabetes mellitus can be reduced by improving the modifiable factors [17].
Predisposing factors of Diabetes Mellitus: The predisposing and risk factors of DM are a bit complex and are associated with non-modifiable and modifiable risk factors. The modifiable risk factors include lifestyle, hypertension, smoking, poor diet and obesity. The non-modifiable risk factors include age, race, genetics and ethnicity [12].

Risk Factors of Diabetes Mellitus: Diabetes mellitus is the major cause of the chronic pancreatitis (CP) [18-20]. This is nondependent risk factor for mortality in CP patients, with the surgical procedures or not [21-25]. The endocrine pancreatic failure can cause life-threatening problems like severe hypoglycemia [26] or chronic macroangiopathy microgliopathy problems, which are more common in diabetic CP patients than in other diabetic patients [27-29]. Patients range from 41% to 86%. Number of patients (medical, surgical or mixed) [30-33]. Non-functional pancreatic tissue in patients with CP may be due to disease progression or surgery. The role of enzyme secretion in decreasing the diabetes is controversial. It is not possible to estimate the effects of surgical procedures in post-diabetic diabetes for CP patients, as most surgical procedures involve only one type of surgery or patients with CP and other metabolic disorders or non-surgical Are included. This prevents the evaluation of the correct effect of metabolic surgery on the postoperative morbidity of diabetes. As far as we know, compared to conservative treatment, there has not been a major clinical-surgical study in CP patients undergoing surgical treatment [34].
Symptoms of Diabetes: The earliest and common symptoms of diabetes are as follow:
Type-1 and type-2 diabetes were accompanied by excessive urination and fatigue. Irritability, easy fatigue of blurred vision, and excessive thirst for both types of diabetes. The frequency of symptoms was similar in the group of type-1 and type 2-diabetes (p> 0.005), having frequent infections, numbness and tingling in the hands and feet (more common in DM), weight loss (more common in juvenile type diabetes) [35].
Pre-Diabetic Conditions: It is a condition of continuous increased blood glucose level above the normal before development of diabetes. It is a phase prior to development of diabetes. Research showed that globally, about 415 million peoples presented pre-diabetic condition in 2015 and this value may increase to approximately 642 M till 2040 [36].
Insulin Resistance Syndrome (Syndrome X): In the individuals who are obese and suffering from type 2 DM side by side, the association of dyslipidemia, hypertension, hyper insulinemia and hyperglycemia which can result coronary artery disease, stroke and peripheral arterial disease can be result of genetic defect causing insulin resistance, which can be more worsen by obesity. Studies show that the insulin resistance further contributes to increased blood glucose level, which causes hyperinsulinemia, and the continuous increased level of insulin predisposes to increased level of TAG (triglycerides) and more retention of sodium and ultimately causing hypertension. In this way, elevated level of insulin promotes the proliferation of endothelial cells. This whole phenomenon stimulates the initiation of atherosclerosis [10]. Problem Statement: Diabetes, being a chronic disease, is an iceberg disease. The incidence and prevalence of diabetes have increased globally, but a dramatic increase is seen in developing and newly industrialized countries [10].

Diagnosis

Diagnosis of diabetes can be made either by measuring plasma glucose level (random or fasting) or by HBA1C. The randomly measuring plasma glucose can be done after 2 horses of taking any some food.
Fasting Plasma Glucose Level: After 8 hours of meal or overnight fasting, a blood sample is taken. The value greater than 126 mg/dl is an indicator of diabetes.
Oral Glucose Tolerance Test: The procedure of this test involves the measurement of the level of plasma glucose 2 hours before and after ingesting 75mg of glucose. If the plasma level of glucose in the second sample (after 2 hours of ingesting glucose) is greater than 200mg/dl, diabetes is diagnosed.
HbA1C: HbA1C gives the average levels of blood glucose levels over the last 3 months. It is a standardized, convenient and rapid test. One of its drawbacks is its high cost. HbA1C greater than 6.5 % is diagnostic for diabetes [37].
Blood Glucose Levels: The normal, pre-diabetic and diabetic blood glucose levels are as follow [38].
Diabetes and Peripheral Arterial Diseases: Studies show that that diabetes and peripheral arterial diseases are linked with each other. Diabetes is a risk enhancer in peripheral arterial diseases i.e., atherosclerosis. It is observed that even with the improvements in treatments and investigation standards, the risk of peripheral vascular disease is higher in diabetic patients as compared to non-diabetic patients so with diabetes and PAD have more significant probability and negative outcomes than non-diabetic patients. People with diabetes type 2 and PAD have a higher risk of amputation in lower extremity, and a higher risk of coronary heart disease. Over 5 years, 20% of diabetics with PAD will develop myocardial infarction or stroke and 30% will die of heart disease. Patients with ischemia: 30% remission and 20% will die within 6 months [38].
Peripheral Arterial Disease: Peripheral arterial disease (PAD) is caused by atherosclerosis, which can cause arteries to narrow or occlude, resulting in less blood flow to the affected arteries [39]. It is also called peripheral vascular disease and may be an increased risk factor for other vascular events [40]. This disease has become an important issue in the field of health because it not only affects daily activities and other physical activities, but also affects mental health [41], which significantly affects the quality of life of patients [42-43]. There are approximately 236 million people in the world. 23.6 hundred people long-lived and older are affected by PAD [44]. According to reports, 15 countries include more than two-thirds of global PAD cases in 2015.In Western countries, despite the declining incidence of disease, the mortality rate of PAD has been increasing for many years [45-46]. With the general aging of the population as well as the increasing complexity of the associated diseases, this trend is expected to become commonplace in the future [47]. Proper blood flow to the affected limb is important, otherwise it will lead to increased stiffness and severe limb ischemia (CLI) symptoms, accompanied by resting pain and cramps in the affected limb. When a patient develops CLI, the estimated 1-year survival rate with two limbs is only 45% [48]. Finally, endovascular treatment (EVT) is easily performed as a first-line rehabilitation intervention for the treatment of PAD, and surgery provides an alternative to EVT [49-50]. However, these interventions are not often tolerated, especially for patients with high risk factors and most debilitating diseases, such as heart disease (CVD) and diabetes (DM), which can sometimes lead to muscle loss. Become the cause of death or death [51]. Therefore, the long-term success of revascularization should be measured by preventing amputation and reducing the burden of symptoms [52]. The efficacy and long-term consequences of the intervention are generally evaluated by clinical measures of implant-free survival (AFS), because over time, such organ-related results are useful for measuring survival rates and organ defense capabilities [53]. In contrast, different risk factors for PAD (such as smoking, diabetes, cardiovascular disease) have been reported [54]. However, the risk factors that affect the results of AFS after revascularization have not been determined. The purpose of this study is to determine the risk factors associated with the reduction of AFS in PAD patients after intravascular or surgical intervention and use these transformative and irreversible risk factors useful information that can develop on the basis of evidence-based interventions, providing better facilities for patients’ long-term recovery [54].
Mechanism of Disease Onset: The development of PAD involves the atherosclerosis in the major large vessels including aorta (abdominal part), iliac artery and femoral artery Figure 2. The process of atherosclerosis initiates with the interaction between the vascular cells and cholesterol. The atherosclerotic plaque is formed gradually inside the any of above arteries. In the initial stage of PAD, the arteries dilate to compensate the plaque and to preserve the flow of blood through vessels. On the progression of the disease, the arteries cannot further dilate, and the plaque causes vessel stenosis and blocks the blood flow. This blockage in the flow of blood represents the hallmark and clinical manifestations of PAD and associated typical signs and symptoms [55]. As the severity of hypoxia increases, microvascular adaptation becomes unbearable. Completely replace mitochondrial damage and free radical generation and subsequent muscle fiber damage, muscle fiber degeneration and fibrosis. These changes ultimately lead to hypoxia and better metabolic requirements, such as discomfort, extreme pain that cannot be improved or damage the body, and then debilitates the organs. Blue represents the direction of blood flow to the muscles, and white represents increased blood pressure in severe cases [56].

Risk Factors: Risk factors, medical management, and intravascular interventions are considered key strategies for the treatment and management of PAD [40]. Current systematic reviews have found that older age, male gender, African American race, lower BMI, higher risk and associated dietary coordination (CVD, kidney disease, DM, dementia, detailed PP). Severe cases of PAD and other medical complications have been identified as risk factors for AFS. This study is similar to previous studies and used to predict long-term outcomes (e.g., remission and survival) of PAD patients after treatment [57-58]. The factors involved in these risks are divided into personal and impersonal, which will be discussed below. European Society of Cardiology Card (ESC) 2017 Chiropractic Recommendations Check (CRC) and manage Chiropractic recommendations for diagnosis and treatment guidelines [40]. According to research, these conditions include weight and food hazards, including defects and abilities. First, obesity is similar to the pathophysiological pathway of atherosclerosis and is a risk factor for ischemic events [59].
Signs and Symptoms: Peripheral artery disease usually asymptomatic but some patient shows generalized nonspecific symptoms. Patient may complain fatigue, numbness in hand and feet and burning sensation in the sole of feet especially at night [35]. There are different modes of signs and symptoms in the patient having peripheral artery disease. Mostly patient discomfort during walking and having pain in legs. There are two most severe symptoms that mostly appear after some time include intermittent claudication and rest pain in legs. The aortoiliac disease patient may also suffer from buttock and thigh discomfort. In PAD, due to accumulation of lactic acid in muscles patient may also suffer from some failure of power sense as they cannot be able to walk for longer period of time and need to sit after 15-20 minutes of walk named as claudication [60]. Intermittent claudication is the discomfort of legs, pain and cramping with due to heavy activity such as running and exercise. The pain mainly noticed in the calf but may also be felt in the buttocks or thighs. The pain must be severe enough that cause difficulty with normal walking and that pain can be caused due to the decreased in blood flow in legs muscles. This type of pain can be treated by having rest as the leg muscles relaxed during low blood flow. The claudication remains stable about 70-80 % in patient for 10 years of period [61]. Rest pain in legs occur in PAD patient when there is no proper supply of oxygen and blood in legs muscles, and it is more severe condition when this can affect the feet even during night when patient lying with face up [62]. The common signs and symptoms include coldness in lower leg and foot, toes and foot become sore that won’t heal, legs skin become shiny, weak pulse in your legs or feet, hair loss on feet and legs, slower growth of toenails and change in legs color [63].
Diagnosis of PAD: The diagnosis of PAD is medically important for two reasons. The first is to identify patients at risk of advanced myocardial infarction or stroke, even those with symptoms of peripheral arterial disease. The second is the detection and treatment of PAD symptoms, which may be related to dysfunction and organ failure. The symptoms of PAD in diabetic patients are usually more subtle than those in diabetic patients. Patients with diabetes are at higher risk of developing PAD and hemorrhage than proximal and near-atherosclerotic lesions, which are more common in high-risk patients. In particular, PAD in diabetic patients usually has a poor prognostic response to peripheral neuropathy. Therefore, the general serious medical history may be less common. However, patients may experience more subtle symptoms, such as leg fatigue and slow walking, which can only be considered wiretapping. The report pointed out that patients with PAD and diabetes have lower body counts than single patients [64]. In addition, diabetic patients identified with PAD are at higher risk of sudden ischemia of arterial thrombosis [65] or a significant event that may lead to neurobiochemical ulceration or infection resulting in severe peripheral arterial disease causes the limb ischemia. PAD with diabetes leads to gangrene formation in effected area, contributing long term disorder and disability due to functional impairment that’s other very severe. People with aortic stenosis walk slowly (usually less than 2 miles per hour) and have limited walking distance. This may lead to a “helpless cycle” with gradual dysfunction and loss of function. Finally, the medical care, productivity decline, and personal expenditures associated with chronic manifestations of PAD (such as atherosclerotic disease) can bring huge economic costs [66].
Differential Diagnosis: The physical examination and clinical history are essential in the diagnostic procedure of PAD, it must be distinguished from other type of claudication [35].
Management: The PAD can be managed by the primary care and some modifications in risk factor that can cause PAD. These risk factors include high blood pressure, age, smoking, hypercholesterolemia, family history and physical inactivity. Person aged 65-70 are at increased risk of having PAD. The incidence ratio of PAD is about 14.5% in aged between 65-70 and the ratio in older than 40 years is 4.3% [67]. If the risk factors are managed than it will prevent the progression of PAD. Smoking, hypercholesterolemia and physical inactivity are the most important risk factors that can cause PAD. For hypercholesterolemia, static drugs are advised by the doctor that are used to lower the cholesterol level mainly low-density lipoprotein (LDL). These risk factors can be treated according to doctor’s guideline. For the PAD management, person should quit smoking as smoker have high incidence rate then nonsmoker and it is compulsory to maintain body index. If body mass index is greater than 25then person should maintain body weight. It the body wait is higher according to body mass index than the person should lose its weight and do exercise regularly [68,69]. Patient should receive antiplatelet therapy to prevent progression of PAD. Some recent analysis shoes that the use of clopidogrel drug is more effective to prevent PAD then aspirin. Continuously use of more than one antiplatelet drug are not recommended for the patient that are at low risk. The use of warfarin drug is not routinely recommended for the patients having PAD unless they have a separate prescription for its use [70].
Prognosis: The prognosis of the PAD depends upon the patient’s risk factors, severity of disease, any comorbidity and cardiovascular health status. Regarding the lower extremity health in 5 years, almost 80 % of the patients show the symptoms of stable claudication. Just in 1-2% patients, the disease progresses to serious extremity ischemia in 5 years. Within 5 years, the 20- 30% of patients suffering from PAD, die out of which almost 70% patients suffered from cardiovascular damage/event [71].

Diabetes and Its Association with PAD

In peripheral arterial disease associated with diabetes, the increased level of glucose and abnormal lipid profile leads to dysfunction of endothelium of vessels, which causes dysfunction of vessel’s smooth muscle cells leading to inflammatory reaction and results in hypercoagulability state which play a vital role in development of arteriopathy associated with diabetic condition. The occurrence of peripheral vascular disease, in addition to its increased risk of ischemia, ulcers, gangrene formation and resulting amputation, is a risk factor for generalized atherosclerosis and cardiovascular disorders i.e., myocardial infarction and stroke [72- 73]. The patients suffering from diabetes and PAD simultaneously are at higher risk of development of morbidity and increased mortality from CVS diseases and increased rates of lower limb amputation. This resulting higher risks of amputation in patients suffering from diabetes is because of dry gangrene development, ulcers in foot which develops secondary to the PAD, and latestage presentation of patients with PAD. Approximately two-third of patients of diabetes having foot ulcers also have PAD, that is associated with greater risk of amputation and death rate. (Table 1) The PAD prevalence is almost 4 times greater and serious in diabetic patients as compared to patients who are not diabetic. The worldwide PAD prevalence is almost 200 million [74].

Pathophysiology

High blood sugar level and increased cholesterol level causes endothelial injuries. The reactive oxygen species are formed that oxidize LDL (low density lipoproteins) Figure 3. These products causes’ plaque formation as described above and causes vessel stenosis. These vascular changes can also lead to the thinning and hardening of vessels. Ultimately, these all-pathological changes results in development of peripheral arterial disease (PAD). Peripheral Arterial disease And Amputation of Lower Extremities The risk of lower limb amputation is increased by the peripheral arterial disease. It, itself an independent variant and indicator of cerebrovascular and cardiovascular disease, thus affect not only the quality of life but also the life expectancy. Studies have shown the prevalence of peripheral arterial disease in the patients suffering from diabetes mellitus is higher than in patients who are nondiabetic. In the patients suffering from diabetes, the peripheral; arterial disease occurs with high progression rate and usually remains asymptomatic. Many metabolic problems in diabetes i.e. HBA1c elevated level, abnormal oxidative stress, high level of LDL and constant hyperglycemic state have shown to worsening the pre-existing peripheral arterial disease [75,76].

Diabetic Foot

Figure 4 Diabetic foot is also a complication caused by peripheral arterial disorder in the lower extremities of diabetic patient. The mechanism of this disorder is given below [76]:

Epidemiology

Epidemiological studies done globally have shown an association and link between diabetes and increased cases of peripheral arterial disease. Although patients usually do not show any symptoms, almost one-third of the patient’s complaint the intermittent blockage, presented as cramping, aching, numbness and tingling in the affected extremity which started on exertion and relieved by rest. Research showed that almost 12 million peoples in U.S suffered from peripheral arterial disease out of which approximately 20-30% of such patients are diabetic [77]. Studies showed, in 2011, almost 366 million people globally, or almost 8 % in the age group of 20-79 years had type 2 diabetes. This percentage is estimated to rise up to almost 550million by the year 2030. Greater than 50% of patients suffering from diabetes die due to any cardiovascular event i.e. myocardial infarction and stroke [78].

Diagnosis protocol

The diagnostic protocol can be followed as below [79].

Risk Factors for Diabetes and Associated PAD: The two main risks of PAD are smoking and diabetes. Both of these risk factors are related to heart disease and stroke, but especially more so with PAD. Based on a PAD diagnosis of ABI 0.9, the relative risk of PAD was 4.05 for diabetes and 2.55 for current smoking in heart health studies (CSS) (Tables 2-4) [80-82].

Preventive Measures: To prevent development of diabetes and associated PAD, following preventive measures should be done by exercise regularly, quit smoking, lower blood pressure, lower cholesterol level and maintain normal blood sugar level [83].

Conclusion and Future Perspectives: Diabetes is a chronic progressing disorder which can be associated with serious complications i.e. PAD is not controlled and diagnosed. PAD can result in disability due to amputation of limb. Diabetes associated with PAD leads to severe cardiovascular damage resulting myocardial infarction and stroke thus, increases mortality and morbidity rates. Diabetes and associated PAD can be prevented by avoiding and minimizing risk factors. Diabetes is one of the commonest and most prevalent disease in Pakistan. PAD is its one of the major and serious complication. Previous studies and all above given discussion shows that it is increasing day by day and thus increasing mortality and morbidity rate. Amputation of limbs due to ulceration and gangrene is one of the major manifestations of developing PAD. With the advancement of medical knowledge and in this era of technology, many investigatory methods have been introduced to investigate and diagnose such complicated disease earlier and sooner so that it can be treated and managed as soon as possible, and the resulting complications can be avoided. The risk factors causing diabetes and its associated PAD can be reduced by lifestyle changes and preventive measures should be adopted to reduce the risk of development of the disease and its complications if the risk factors are irreversible. If the disease is initiated, continuous medical care should be taken, with regular follow up investigations to keep the prognosis of the disease slow and to prevent further complications. If primordial and primary interventions are not adopted and disease’s clinical manifestations are presented, the secondary interventions should be done to prevent any further serious illness, PAD and disability due to limb amputation (Table 5).

With advancement of medical technology, more efficient methods of investigations and management and treatments are introduced. By adding primordial and primary modes of interventions with these techniques and management, the risk of development of diabetes and its associated PAD can be prevented. However, the changing sedentary lifestyles and increasing risk factors increase the rate of development of this disease and more serious complications.

Conflict of Interest

The authors declare no conflict of interest, financial or otherwise.

Acknowledgements

We acknowledge the support of Department of Biochemistry, University of Central Punjab, Lahore, Pakistan.

References

1. Unwin N, Whiting D, Guariguata L (2013) International Diabetes Federation. IDF diabetes atlas. Brussels, Belgium: International Diabetes Federation; 2012.
2. Chen L, Magliano DJ, Zimmet PZ (2012) The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives. Nature reviews endocrinology 8(4): 228-236.
3. Zimmet PZ, Magliano DJ, Herman WH, Shaw JE (2014) Diabetes: A 21st century challenge. The lancet Diabetes & endocrinology 2(1): 56-64.
4. Nanditha A, Ma RC, Ramachandran A, Snehalatha C, Chan JC, et al. (2016) Diabetes in Asia and the Pacific: implications for the global epidemic. Diabetes care 39(3): 472-485.
5. Akalu Y, Birhan, A (2020) Peripheral arterial disease and its associated factors among type 2 diabetes mellitus patients at Debre Tabor general hospital, Northwest Ethiopia. Journal of diabetes research 2020.
6. Bloomgarden ZT (2006) Developments in diabetes and insulin resistance. Diabetes Care 29(1): 161-167.
7. Petersen MC, Shulman GI (2018) Mechanisms of insulin action and insulin resistance. Physiological reviews 98(4): 2133-2223.
8. Ota A, Ulrih NP (2017) An overview of herbal products and secondary metabolites used for management of type two diabetes. Frontiers in pharmacology 8: 436.
9. DiMeglio LA, Evans-Molina C, Oram RA (2018) Type 1 diabetes. The Lancet 391(10138): 2449-2462.
10. Tierney Jr LM (2002) Stephen J. McPhee, Maxine A. Papadakis, Current Medical Diagnosis and Treatment forty.
11. Paschou SA, Papadopoulou-Marketou N, Chrousos GP, Kanaka-Gantenbein C (2018) On type 1 diabetes mellitus pathogenesis. Endocrine connections 7(1): R38-R46.
12. Sami W, Ansari T, Butt NS, Ab Hamid MR (2017) Effect of diet on type 2 diabetes mellitus: A review. International journal of health sciences 11(2): 65-71
13. Sobel BE, Schneider DJ (2005) Cardiovascular complications in diabetes mellitus. Current Opinion in Pharmacology 5(2): 143-148.
14. Nathan D, Cleary P, Backlund J (2005) Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353: 2643-2653
15. Martín-Timón I, Sevillano-Collantes C, Segura-Galindo A, del Cañizo-Gómez FJ (2014) Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength? World J Diabetes 5(4): 444-470.
16. Roglic G (2016) WHO Global report on diabetes: A summary. International Journal of Noncommunicable Diseases 1(1): 3-8
17. Basit A, Fawwad A, Qureshi H, Shera AS (2018) Prevalence of diabetes, pre- diabetes and associated risk factors: second National Diabetes Survey of Pakistan (NDSP), 2016-2017. BMJ open 8(8): e020961.
18. Ammann RW, Akovbiantz A, Largiader F, Schueler G (1984) Course and outcome of chronic pancreatitis. Longitudinal study of a mixed medical-chirurgical series of 245 patients. Gastroenterology 86: 820-828.
19. Bernades P, Belghiti J, Athouel M, Mallardo N, Breil P, et al. (1983) Histoire naturelle de la pancre´atitechronique: e´tude de 120 cas. Gastroenterol Clin Biol. 7: 8-13.
20. Ammann RW, Muellhaupt B, Zurich Pancreatitis Study Group (1999) The natural history of pain in alcoholic chronic pancreatitis. Gastroenterology 116: 1132-1140.
21. Traverso LW, Kozarek RA (1997) Pancreatoduodenectomy for chronic pancreatitis: anatomic selection criteria and subsequent longterm outcome analysis. Ann Surg. 226(4): 429-438.
22. Sato T, Miyashita E, Yamauchi H, Matsuno S (1986) The role of surgical treatment for chronic pancreatitis. Ann Surg 203: 266-271.
23. Eckhauser FE,          Strodel   WE,        Knol       JA,           Harper   M,           Turcotte                JG (1984) Neartotalpancreatectomy for chronic pancreatitis. Surgery. 96: 599-607.
24. Petrin P, Andreoli A, Antoniutti M, Zaramella D, Da Lio C, et al. (1995) Surgery for chronic pancreatitis: what quality of life ahead?. World journal of surgery 19(3): 398-402.
25. Linde J, Nilsson LH, Barany FR (1997) Diabetes and hypoglycemia in chronic pancreatitis. Scand J Gastroenterol 12: 369-373.
26. Koizumi M, Yoshida Y, Abe N, Shimosegawa T, Toyota T (1998) Pancreatic diabetes in Japan.

Pancreas. 16(3): 385-391.

26. Gullo L, Parenti M, Monti L, Pezzilli R, Barbara L (1990) Diabetic retinopathy in chronic pancreatitis. Gastroenterology 98: 1577-1581.
27. Ziegler O, Candiloros H, Guerci B, Got I, Crea T, et (1994) Lowerextremity arterial disease in diabetes mellitus due to chronic pancreatitis. Diabetes Metab 20(6): 540-545.
28. James O, Agnew JE, Bouchier IAD (1974) Chronic pancreatitis in England: a changing picture? BMJ 2 (5909): 34-38.
29. Lankisch PG, Otto J, Erkelenz I, Lembcke B (1986) Pancreatic calcifications: no indicator of severe exocrine pancreatic insufficiency. Gastroenterology 90(3): 617-621.
30. Lankisch PG, Lohr-Happe A, Otto J, Creutzfeldt W (1993) Natural course in chronic pancreatitis. Pain, exocrine and endocrine pancreatic insufficiency and prognosis of the disease. Digestion 54(3): 148-155.
31. Cavallini G, Frulloni L, Pederzoli P, Talamini G, Bovo P, et al. (1983) Long-term follow-up of patients with chronic pancreatitis in Italy. Scand J Gastroenterol 33(8): 880-889.
32. Malka D, Hammel P, Sauvanet A, Rufat P, O'Toole D, et al. (2000) Risk factors for diabetes mellitus in chronic pancreatitis. Gastroenterology 119(5): 1324-1332.
33. Clark NG, Fox KM, Grandy S (2007) Symptoms of diabetes and their association with the risk and presence of diabetes: findings from the Study to Help Improve Early evaluation and management of risk factors leading to Diabetes (SHIELD). Diabetes Care 30(11): 2868-2873.
34. Khetan AK, Rajagopalan S (2018) Prediabetes. Canadian Journal of Cardiology 34(5): 615-623.
35. Goyal R, Jialal I (2020) Diabetes Mellitus Type 2 Stat Pearls.
36. Hassali MA, Nazir SU, Saleem F, Masood I (2015) Literature review: pharmacists’ interventions to improve control and management in type 2 diabetes mellitus. Altern Ther Health Med 21(1): 28-35.
37. Beckman JA, Paneni F, Cosentino F, Creager MA (2013) Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II. European heart journal. 34(31): 2444-2452.
38. Aboyans V, Ricco J-B, Bartelink M-LEL, Bjo¨rck M, Brodmann M, et al. (2018) ESC Scientific Document Group. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: Endorsed by: the European Stroke Organization (ESO): The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J 39: 763-816.
39. Emdin CA, Anderson SG, Callender T, Conrad N, Salimi-Khorshidi G, et al. (2015) Usual blood pressure, peripheral arterial disease, and vascular risk: cohort study of 4.2 million adults. BMJ. 351: h4865.
40. Brostow DP, Petrik ML, Starosta AJ, Waldo SW (2017) Depression in patients with peripheral arterial disease: a systematic review. Eur J CardiovascNurs 16(3): 181-193.
41. Aber A, Lumley E, Phillips P, Woods HB, Jones G, et al. (2018) Themes that determine quality of life in patients with peripheral arterial disease: a systematic review. Patient 11(5): 489-502.
42. Marrett E, DiBonaventura M, Zhang Q (2013) Burden of peripheral arterial disease in Europe and the United States: A patient survey. Health Qual Life Outcomes 11: 175.
43. Song P, Rudan D, Zhu Y, Fowkes FJI, Rahimi K, et al. (2019) Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis. Lancet Glob Health 7: e1020-e1030.
44. Goodall R, Salciccioli JD, Davies AH (2020) Trends in peripheral arterial disease incidence and mortality in EU15 countries 1990-2017. European Journal of Preventive Cardiology.
45. Sundaram V, Bloom C, Zakeri R, Halcox J, Cohen A, et al. (2020) Temporal trends in the incidence, treatment patterns, and outcomes of coronary artery disease and peripheral artery disease in the UK, 2006-2015. Eur Heart J 41(17): 1636-1649.
46. Fowkes FGR, Aboyans V, Fowkes FJI, McDermott MM, Sampson UKA, et al. (2017) Peripheral artery disease: epidemiology and global perspectives. Nat Rev Cardiol 14(3): 156-170.
47. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR (2007) Intersociety consensus for the management of peripheral arterial disease (TASC II). J VascSurg 45Suppl S: S5-S67.
48. Bisdas T, Borowski M, Torsello G, Adili F, Balzer K, et al. (2015) Current practice of first-line treatment strategies in patients with critical limb ischemia. J VascSurg 62: 965-973.e3.
49. Londero LS, Høgh A, Houlind K, Lindholt JS (2019) Danish trends in major amputation after vascular reconstruction in patients with peripheral arterial disease 2002- 2014. Eur J Vasc Endovasc Surg. 57: 111-120.
50. Sutton M, Kreider K, Thompson J, Germanwala S, Greifenkamp J (2018) Improving outcomes in patients with peripheral arterial disease. J VascNurs 36(4): 166-172.
51. Conte MS, Geraghty PJ, Bradbury AW, Hevelone ND, Lipsitz SR, et al. (2009) Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia. J Vasc Surg 50: 1462-1473.
52. Dolan NC, Liu K, Criqui MH, Greenland P, Guralnik JM, et al. (2002) Peripheral artery disease, diabetes, and reduced lower extremity functioning. Diabetes Care 25(1): 113-120.
53. Krishna SM, Moxon JV, Golledge J (2015) A review of the pathophysiology and potential biomarkers for peripheral artery disease. International journal of molecular sciences 16(5): 11294-11322.
54. Zemaitis MR, Boll JM, Dreyer MA (2017) Peripheral arterial disease.
55. Bradbury AW, Adam DJ, Bell J, Forbes JF, Fowkes FGR, et al. (2010) Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: a survival prediction model to facilitate clinical decision making. J VascSurg. 51: 52S-68S.
56. Schanzer A, Mega J, Meadows J, Samson RH, Bandyk DF, et al. (2008) Risk stratification in critical limb ischemia: derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data. J VascSurg 48(6): 1464-1471.
57. Rocha VZ, Libby P (2009) Obesity, inflammation, and atherosclerosis. Nat Rev Cardiol 6(6): 399-409.
58. Olin JW, Sealove BA (2010) Peripheral artery disease: current insight into the disease and its diagnosis and management. Elsevier. In Mayo Clinic Proceedings 34(7): 678- 692).
59. Shu J, Santulli G (2018) Update on peripheral artery disease: Epidemiology and evidence-based facts. Atherosclerosis 275: 379-381.
60. Thiruvoipati T, Kielhorn CE, Armstrong EJ (2015) Peripheral artery disease in patients with diabetes: Epidemiology, mechanisms, and outcomes. World journal of diabetes 6(7): 961-969.
61. Berger JS, Hiatt WR (2012) Medical therapy in peripheral artery disease. Circulation 126(4): 491-500.
62. Dolan NC, Liu K, Criqui MH, Greenland P, Guralnik JM, et al. (2002) Peripheral artery disease, diabetes, and reduced lower extremity functioning. Diabetes Care 25(1): 113-120.
63. McDaniel MD, Cronenwett JL (1989) Basic data related to the natural history of intermittent claudication. Ann VascSurg 3(3): 273-277.
64. American Diabetes Association (2003) Peripheral arterial disease in people with diabetes. Diabetes care 26(12): 3333-3341.
65. Regensteiner JG, Hiatt WR, Coll JR, Criqui MH, Treat-Jacobson D, et al. (2008) The impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) Program. Vascular medicine 13(1): 15-24.
66. Olin JW (2005) Masterclass series in peripheral arterial disease: Hypertension and peripheral arterial disease. Vascular medicine 10(3): 241-246.
67. National Institute for Health and Care Excellence (Great Britain), (2018) Peripheral arterial disease: diagnosis and management. National Institute for Health and Care Excellence (NICE).
68. Peach G, Griffin M, Jones KG, Thompson MM, Hinchliffe RJ (2012) Diagnosis and management of peripheral arterial disease. BMJ 345: e5208.
69. Duane R, Hennion MD, Kelly A, Siano, MD, Tripler Army Medical Center, Honolulu, Hawaii (2013) Am FamPhysicianDiagnosis and Treatment of Peripheral Arterial Disease 88(5): 306-310.
70. Dao VD, Awaken You Wonderful We: The secret of one-page table reveal all the real causes of all phenomena and problems: Most phenomena, physical problems, mental problems, social problems and how to solve them: Ability. Autoimmune diseases, Belief system, Gut feelings, Hysteria, Learning, Learning difficulties, mental problems, ADHD, Alcohol use disorders, Anxiety disorders, Autism, Behavioral Disorders, Depression.
71. Nelson B (2017) Sex Differences and the Effects of Exercise Training on Functional Vasodilation Following Arterial Occlusion in the BALB/c Mouse Spinotrapezius.
72. Gul F, Janzer SF (2021) Peripheral vascular disease. StatPearls [Internet].
73. Yang SL, Zhu LY, Han R, Sun LL, Li JX, Dou JT (2017) Pathophysiology of peripheral arterial disease in diabetes mellitus: Journal of diabetes 9(2): 133-140.
74. Berceli SA, Chan AK, Pomposelli Jr FB, Gibbons GW, Campbell DR, Akbari CM, Brophy DT, LoGerfo FW (1999) Efficacy of dorsal pedal artery bypass in limb salvage for ischemic heel ulcers. Journal of vascular surgery 30(3): 499-508.
75. Marso SP, Hiatt WR (2006) Peripheral arterial disease in patients with diabetes. Journal of the American College of Cardiolog 47(5): 921-929.
76. Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, et al. (2017) 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American College of Cardiology 69(11): e71-e126.
77. Criqui MH, Fronek A, Klauber MR, Barrett-Connor E, Gabriel S (1985) The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: results from noninvasive testing in a defined population. Circulation 71(3): 516-522.
78. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR. Large vessel and isolated small vessel disease. In: Fowkes FGR (ed) (1995). Epidemiology of peripheral vascular disease. London: Springer-Verlag. 85-96.
79. Newman AB, Siscovick DS, Manolio TA (1993) Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation 88: 837-845.
80. Criqui MH (2001) Peripheral arterial disease-epidemiological aspects. Vascular medicine 6(1_suppl): 3-7.
81. Nanditha A, Ma RC, Ramachandran A, Snehalatha C, Chan JC, et al. (2016) Diabetes in Asia and the Pacific: implications for the global epidemic. Diabetes care 39(3): 472-485.
82. Jude EB, Oyibo SO, Chalmers N, Boulton AJ (2001) Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Diabetes care 24(8): 1433-1437.

Abstract

Diabetes is one of the most common diseases that are more prevalent in Pakistan. One of the major vascular complications of diabetes is peripheral arterial disease (PAD), which is associated with peripheral vascular damage and cardiovascular diseases. This complication enhances the risk of disability due to amputation of lower extremity in the patients suffering from diabetes. The early diabetic diagnosis and with therapy of the peripheral arterial disease, patients can minimize the risks of microvascular and macrovascular damage and resulting peripheral arterial disease. Thus, this step can help to reduce the cardiovascular complications and risks of amputation of extremity in such patients. The early diagnosis includes the assessment of blood sugar level. HBA1c is one of the standard markers to check the diabetes status in patients. The clinical presentations including polydipsia, polyuria and increased thirst also indicate towards diabetes susceptibility. The development of diabetes complications including neuropathy, myopathy, retinopathy, nephropathy and peripheral arterial disease point towards the sustained increased level of blood sugar (glucose) and condition is known as uncontrolled diabetes. The development of PAD can be prevented by early recognition of disease onset and by controlling the blood sugar level.

Keywords: Amputation; Diabetes Mellitus; Glucose; Hba1c; Lower Extremity; Peripheral Arterial Disease